01.002 RWE KR June 2022 J 12-07-2022

Combining RCTs and RWE studies to alter the regulatory approval process

  • Hybridisation of RCTs and RWE studies reinforce the benefits of both, while reducing the limitations of traditional study formats
  • The potential of real-world data that provides adequate scientific evidence for regulatory decision-making is being realised
  • Innovative study designs must be developed to unlock this potential
Click here to learn more.

About SVMPharma

SVMPharma is an innovative strategic consultancy and CRO, with a focus in Real World Evidence (RWE) for pharmaceutical and biotechnology companies. SVMPharma delivers clinical trials within UK and Europe.


DISTILL is a new EDC launched by SVMPharma. As a CRO discover the benefits of DISTILL as part of your service offering and take back control of your clinical trials. DISTILL allows you to develop and manage every aspect of your trials from start to finish. Move away from the restrictions and costs associated with legacy systems.

For more information, please visit and contact us at